Ann: Interim Financial Report and ASX Appendix 4D, page-90

Re: 3DM. I'm not saying (because in fact I have no idea) whether or not this company has good potential or whether the SP will rise on re-listing tomorrow. The general concept of 3D printing of scans is one that has been around for a while and I am confident it will become common practice in a short while. But 3D printing in itself is not difficult and there are few barriers to entry.

What worries me most about the company is that it is a "reverse take-over" by another company (Safety Medical Products) which has two existing interests (1) a "safe Syringe" and (2) a 37 sq km gold tenement in WA.

This strikes me as (potentially) one of the 2c stocks that day-traders love which eventually turn to nothing but make the owners a small fortune. Maybe in a few months time when the biotech market dies down a bit it will go back to being a pure gold exploration stock. Who knows.

Interesting that the CAJ directors are stakeholders though, maybe in the medium term there is a prospect of 3DM being taken over by CAJ.

Anyway, DYOR and good luck to those who want to have a flutter.